Literature DB >> 6946625

Control of blood vessel development.

R W Bellhorn.   

Abstract

Metabolic demands of the ocular tissues are determinants for the presence, morphology, and permeability of the ocular blood vessels. Changes in those metabolic requirements, such as those which occur during tissue maturation or a disease process, can lead to an alteration of the unique permeability and morphology of each nutrient vessel system. Those alterations during the course of a disease are the basis for the well-known visually destructive complications associated with vascular retinopathies. In order to prevent or circumvent those complications, we must come to understand both normal and abnormal tissue environmental factors which are determinants of vessel morphology and permeability. Investigations of those determinants in animals having fully, partially, or non-vascularized retinae and in animals with experimental retinopathies are necessary to the understanding of tissue/blood vessel inter-relationships. It is also necessary to evaluate those same relationships as fully as possible in human eyes with and without vascular abnormalities. Then we can begin to understand and to control blood vessel development.

Entities:  

Mesh:

Year:  1980        PMID: 6946625

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  4 in total

1.  Development of the retinal circulation in the pig.

Authors:  L De Schaepdrijver; P Simoens; H Lauwers
Journal:  Anat Embryol (Berl)       Date:  1995-12

2.  Experimental studies on the angiogenic activity of the detached retina.

Authors:  M Prost
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Ultrastructure of retinal vessels in diabetic patients.

Authors:  T Ishibashi; H Inomata
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  Photoreceptor Cells Influence Retinal Vascular Degeneration in Mouse Models of Retinal Degeneration and Diabetes.

Authors:  Haitao Liu; Jie Tang; Yunpeng Du; Aicha Saadane; Deoye Tonade; Ivy Samuels; Alex Veenstra; Krzysztof Palczewski; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.